Idarubicin
- Generic Name
- Idarubicin
- Brand Names
- Idamycin
- Drug Type
- Small Molecule
- Chemical Formula
- C26H27NO9
- CAS Number
- 58957-92-9
- Unique Ingredient Identifier
- ZRP63D75JW
- Background
An orally administered anthracycline antineoplastic. The compound has shown activity against breast cancer, lymphomas and leukemias, together with the potential for reduced cardiac toxicity.
- Indication
For the treatment of acute myeloid leukemia (AML) in adults. This includes French-American-British (FAB) classifications M1 through M7.
- Associated Conditions
- Acute Myeloid Leukemia
- Associated Therapies
- -
Amifostine and Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
- Conditions
- Locations
- 🇺🇸
Kimmel Cancer Center of Thomas Jefferson University - Philadelphia, Philadelphia, Pennsylvania, United States
Chemotherapy in Treating Children With Recurrent Acute Myeloid Leukemia
- Conditions
- Interventions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2014-07-25
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 120
- Registration Number
- NCT00003178
- Locations
- 🇺🇸
Simmons Cancer Center - Dallas, Dallas, Texas, United States
🇺🇸Rush-Presbyterian-St. Luke's Medical Center, Chicago, Illinois, United States
🇺🇸Children's Memorial Hospital - Chicago, Chicago, Illinois, United States
Chemotherapy, Interferon, and Bone Marrow Transplantation in Treating Patients With Chronic Myelogenous Leukemia
- Conditions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2013-08-02
- Lead Sponsor
- German CML Study Group
- Target Recruit Count
- 750
- Registration Number
- NCT00002771
- Locations
- 🇩🇪
III Medizinische Klinik Mannheim, Mannheim, Germany
Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome
- Conditions
- Locations
- 🇫🇷
Centre Hospitalier Regional et Universitaire d'Angers, Angers, France
🇧🇪Algemeen Ziekenhuis Middelheim, Antwerp, Belgium
🇧🇪Hopital Universitaire Des Enfants Reine Fabiola, Brussels, Belgium
Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Myelodysplastic Syndrome or Acute Myelogenous Leukemia
- Conditions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2010-05-27
- Target Recruit Count
- 80
- Registration Number
- NCT00002926
- Locations
- 🇧🇪
Hopital Universitaire Erasme, Brussels, Belgium
🇧🇪Cliniques Universitaires Saint-Luc, Brussels, Belgium
🇨🇿Institute of Hematology and Blood Transfusion, Prague, Czech Republic
Chemotherapy Plus Steroid Therapy in Treating Patients With Multiple Myeloma
- Conditions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2013-09-20
- Lead Sponsor
- Riverside Haematology Group
- Target Recruit Count
- 660
- Registration Number
- NCT00003603
- Locations
- 🇬🇧
Hammersmith Hospital, London, England, United Kingdom
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.